Official Title
Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to Sars-covid-2: a Randomized Crossover Trial.
Brief Summary

The main manifestation of COVID-19 is acute hypoxemic respiratory failure (AHRF). In patients with AHRF, the need for invasive mechanical ventilation is associated with high mortality. Prone positioning (PP) is a recommended strategy for patients with moderate to severe acute respiratory distress syndrome (ARDS) undergoing invasive mechanical ventilation. Early PP combined with High Flow Oxygen Therapy may benefit spontaneous breathing patients with AHRF due to COVID-19 as recently reported in Jiangsu. Our hypothesis is that early PP combined with High Flow Oxygen Therapy in patients with AHRF due to COVID-19 improves oxygenation.

Completed
COVID19

Other: Prone position

prone positioning in spontaneous ventilation

Other: Supine position

supine positiong in spontaneous ventilation

Eligibility Criteria

Inclusion Criteria:

- Aged ≥ 18 years,

- Admitted to ICU within 72 hours,

- Having confirmed or highly suspected COVID-19 infection (positive RT-PCR and/or
computed tomography),

- Having acute hypoxemic respiratory failure with a [PaO2/FiO2] ratio between 100 mmHg
and 300 mmHg,

- Having given free and informed written consent,

- Being affiliated with or benefiting from a social security scheme.

Exclusion Criteria:

- Unable to achieve a prone position for mobility reasons,

- Unable to achieve a prone position due to agitation whatever the cause,

- With clinical occlusive syndrome in order to limit the risk of inhalation,

- Having a contraindication to the use of the esophageal catheter,

- Having signs of respiratory distress or disturbance of consciousness requiring
intubation within the next hours,

- Having hypercapnia indicating the use of non-invasive ventilation (PaO2> 50 mmHg),

- Having severe hypoxemia defined by PaO2 / FiO2 <100mmHg,

- Ongoing pregnancy or breastfeeding,

- Subject to a measure for the protection of justice.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

Hopital Européen
Marseille, France

Hopital La Timone
Marseille, France

Hopital Saint Joseph
Marseille, France

Hopital Nord
Marseille, France

Samuel LEHINGUE, M.D, Principal Investigator
Hopital Saint Joseph Marseille

Hospital St. Joseph, Marseille, France
NCT Number
MeSH Terms
COVID-19
Respiratory Insufficiency